ASIC Corporations (Disclosing Entities) Instrument 2016/190

The instrument operates through two principal relief mechanisms set against the structure of Chapter 2M disclosure obligations.

Relief-by-cessation: Section 5 provides a temporary opt‑out from Chapter 2M obligations where an entity that was a disclosing entity at financial year end stops being a disclosing entity within a prescribed post‑year end period. The relief is limited in scope: it only removes the entity’s obligation "to the extent that those requirements apply to the entity as a disclosing entity" (s 5(1)). The conditions for relief require that, despite the entity having been a disclosing entity at year end, it must comply with Chapter 2M "as if it had not been a disclosing entity at the end of the relevant financial year" (s 5(2)(a)), and directors must resolve before the relevant deadline that there are no reasons to believe the entity will again become a disclosing entity in the next financial year (s 5(2)(b)). The instrument separately treats retail CCIV sub‑funds where ED securities are involved; the definition of disclosing entity explicitly covers that context (s 4).

Short-first-year relief: Section 6 addresses first financial years of eight months or less. For such short first years, an entity that is a disclosing entity (company, registered scheme or retail CCIV sub‑fund) need not comply with s 302 or s 306 for a half‑year within that first year (s 6(1)). The relief is conditional on procedural steps: listed entities must give notice to the operator of each prescribed financial market where listed explaining the effect and stating intent to rely on s 6; unlisted entities must give ASIC a similar notice (s 6(2)(a)(i)-(ii)). The directors’ report for the relevant year must explain the section’s effect and state that the entity relied on it (s 6(2)(b)(i)-(ii)). A timing rule requires the notice to be given on or before the deadline for lodging the reports which would otherwise have been required by s 302 (s 6(2) final paragraph).

Retail CCIV specificities: The instrument treats retail CCIVs both in the cessation relief (s 5(1A)-(2)(a)(ii)) and in the short-first-year relief (s 6(1)(c), s 6(2)(b)(ii)). The definition of "disclosing entity" in s 4(a) states that a retail CCIV is a disclosing entity in relation to a sub‑fund if any securities referable to the sub‑fund are ED securities as defined in subsection 1232F(2) of the Act. The instrument includes notes cross‑referencing the Corporations Act definitions of "listed" and a prohibition on listing multiple retail CCIV sub‑funds (s 6 note 1 and note 2).

Authority and scope: The instrument is made under s 341(1) of the Corporations Act (s 3). It operates by modifying how Chapter 2M requirements are applied to particular entities in specified situations; it does not itself rewrite Chapter 2M or change the underlying definitions beyond clarifying how disclosing entity applies to retail CCIV sub‑funds (s 4).

Entities covered: The instrument explicitly addresses three categories of entities: companies that are disclosing entities, registered schemes that are disclosing entities, and retail CCIVs that are disclosing entities in relation to a sub‑fund (s 6(1)(a)-(c); s 5(1), s 5(1A)). The phrase "disclosing entity" otherwise retains the Act’s definition (s 4(b)), so the instrument operates against the broader population of entities that meet the statutory tests in section 9 of the Act unless specifically carved out or otherwise limited.

Companies and schemes that stop being disclosing entities: Section 5 targets entities that were disclosing entities at the end of a financial year but cease to be disclosing entities shortly thereafter. For companies, the relevant windows are either three months after year end or, where the company must hold an AGM, until 21 days before the next AGM date if that occurs earlier (s 5(1)(a)(i)-(ii)). For registered schemes, the window is three months after year end (s 5(1)(b)). Retail CCIV sub‑funds follow the three‑month rule in s 5(1A).

Entities with short first financial years: Section 6 applies to entities whose first financial year lasts eight months or less. That catch is precise: the relief applies only to "a half‑year within the entity’s first financial year (the relevant financial year) where that year lasts for 8 months or less" (s 6(1)). The covered entities are companies, registered schemes, and retail CCIV sub‑funds (s 6(1)(a)-(c)).

Listed versus unlisted distinction: The instrument differentiates between listed and unlisted entities when imposing procedural requirements for s 6 relief. Listed entities must give a notice to the operator of each prescribed financial market on which they are listed; unlisted entities must instead give a notice to ASIC (s 6(2)(a)(i)-(ii)). The instrument’s notes clarify that a retail CCIV with a single sub‑fund may be treated as listed under the Act’s definition, and that retail CCIVs with multiple sub‑funds cannot be listed (s 6 note 1-2). Therefore market listing status affects where to send the required notice and may affect timing and market operator obligations.

Directors and governance: Directors are singled out for an express role. Under s 5(2)(b), directors must resolve, within the specified period, that there are no reasons to believe the entity may become a disclosing entity in the following financial year. Under s 6(2)(b), the directors’ report must explain the effect of s 6 and state reliance on it. Thus the instrument directly imposes procedural and recordkeeping duties on boards when entities intend to rely on the relief.

Regulators and market operators: ASIC and prescribed financial market operators are recipients of notices required under s 6(2)(a). The instrument therefore generates information flows to those bodies; listed entities must notify the relevant market operator(s), while unlisted entities must notify ASIC.

Those not affected: Entities that remain disclosing entities through the relevant windows are not within the relief. The instrument does not alter the substantive tests in the Act for being a disclosing entity; it only suspends certain Chapter 2M obligations when the specific conditions are satisfied.

Relief entitlement and conditionality: The instrument confers rights to avoid certain Chapter 2M obligations, subject to precise conditions. Under s 5(1) and s 5(1A) an entity that meets the timing conditions acquires the right not to comply "to the extent that those requirements apply to the entity as a disclosing entity." That right is conditional on fulfilling steps in s 5(2): compliance with Chapter 2M as if the entity had not been a disclosing entity at the end of the relevant financial year (s 5(2)(a)) and a directors’ resolution, adopted before the relevant deadline, that there are no reasons to believe the entity may become a disclosing entity in the next financial year (s 5(2)(b)).

Directors’ duties and reporting obligations: The instrument places clear duties on directors to make factual assessments and record them. Under s 5(2)(b), directors must make a forward‑looking resolution about the likelihood of becoming a disclosing entity in the following year. Under s 6(2)(b)(i)-(ii), the directors’ report must explain the effect of the short-first-year relief and state that the entity relied on it. Those are express documentary obligations designed to create a public record in the directors’ report.

Notice obligations: Section 6 imposes notice duties. Listed entities must provide a notice to each prescribed financial market operator in relation to which they are listed, explaining the effect of s 6 and stating the entity’s intention to rely on it (s 6(2)(a)(i)(B)). Unlisted entities must give ASIC a notice stating their intention to rely on s 6 (s 6(2)(a)(ii)(B)). The instrument further specifies that the notice must be given on or before the deadline for lodging the reports which would otherwise have been required under s 302 (s 6(2), final paragraph). Thus timing and recipient of notices create mandatory steps for accessing the relief.

Record-keeping and compliance burden: The rights to relief are accompanied by documentary obligations , directors’ resolutions, explanations in directors’ reports, and external notices , that create identifiable compliance tasks and record‑keeping responsibilities. The instrument explicitly requires that where relief is relied upon the entity must nonetheless "comply with Chapter 2M of the Act as if it had not been a disclosing entity" (s 5(2)(a)) in certain respects; that phrase indicates the entity must still meet those parts of Chapter 2M necessary to satisfy non‑disclosing entity requirements, which is a compliance obligation.

Interaction with the Act’s definitions: The instrument preserves the Act’s definitions, but clarifies how the term "disclosing entity" applies to retail CCIVs by reference to ED securities in subsection 1232F(2) (s 4(a)). The rights and duties therefore operate within the Act’s existing definitional and enforcement architecture.

No express penalties in the instrument: The instrument itself creates relief and procedural duties; it does not set out civil or criminal penalties for failure to comply. Compliance or non‑compliance with the instrument’s conditions will affect whether Chapter 2M obligations apply, and enforcement consequences for failing to meet Chapter 2M duties remain governed by the Act rather than by the instrument itself.

Instrument’s own approach: The instrument itself does not create or state new penalties or criminal offences. It operates by providing conditional relief from Chapter 2M obligations; therefore enforcement of reporting obligations and any penalties for non‑compliance would continue to be governed by the Corporations Act and its enforcement mechanisms rather than by this instrument (s 3 shows the statutory basis under s 341(1) of the Act). The instrument sets out conditions which, if not satisfied, mean the entity will remain subject to Chapter 2M obligations.

Compliance triggers and enforcement pathways: Because the instrument removes particular Chapter 2M obligations only where conditions are satisfied, the practical enforcement question is whether an entity has met the conditions set out in ss 5 and 6. Key trigger points for compliance assessment will be:

• whether the entity ceased to be a disclosing entity within the specified window (s 5(1), s 5(1A));
• whether the entity “complies with Chapter 2M … as if it had not been a disclosing entity at the end of the relevant financial year” (s 5(2)(a));
• whether the directors resolved, before the relevant deadline, that there are no reasons to believe the entity may become a disclosing entity in the next financial year (s 5(2)(b));
• whether, in the short-first-year relief, the entity gave the required notice to the market operator(s) or ASIC and whether the directors’ report explains and records reliance on the relief (s 6(2)(a)-(b)).

These conditions create objective items for regulator inspection: notices to market operators or ASIC and the directors’ report statements are concrete records that can be checked.

Regulator recipients of notices: Section 6 requires listed entities to give notice to the operator of each prescribed financial market in relation to which the entity is listed, and unlisted entities to give notice to ASIC (s 6(2)(a)). Those notices create an information stream to market operators and ASIC which may be used to monitor whether the relief is being invoked properly. The instrument’s design places the burden on the entity to make the notification and on the regulator or market operator to receive the notice; the instrument does not specify further regulatory action following receipt.

Indirect enforcement through Chapter 2M: Because the instrument’s relief is framed as an exception to Chapter 2M rather than an amendment of it, entities that do not satisfy the instrument’s conditions will remain subject to Chapter 2M reporting obligations and any civil or criminal consequences that flow from non‑compliance with those provisions under the Act. The instrument does not itself list those Chapter 2M enforcement mechanisms.

No express audit or review powers in the instrument: The instrument does not prescribe audit processes, bespoke disclosure regimes, or special administrative penalties. The only practical enforcement points are the documentary records (directors’ resolutions and directors’ reports, s 5(2)(b) and s 6(2)(b)) and notices to market operators or ASIC (s 6(2)(a)), which enable third‑party verification. Any action for failure to meet the conditions would proceed under the Corporations Act’s established enforcement framework.

Operates under the Corporations Act: The instrument is made under subsection 341(1) of the Corporations Act 2001 (s 3). Its entire effect is to modify the application of Chapter 2M of the Act to specified entities in particular circumstances. It therefore functions as a subordinate legislative instrument that alters how existing statutory duties apply rather than replacing them.

References to specific chapters and sections: The relief in s 5 refers explicitly to "the requirements of Chapter 2M of the Act" and prescribes that entities seeking relief "comply with Chapter 2M … as if it had not been a disclosing entity at the end of the relevant financial year" (s 5(1), s 5(2)(a)). Section 6 removes the requirement to comply with sections 302 and 306 for parts of a short first financial year (s 6(1)). Those cross‑references mean the instrument cannot be read in isolation: the content and scope of the relief depend on the provisions of Chapter 2M and the detail in ss 302 and 306, which set out annual and half‑year reporting obligations respectively.

Interaction with Corporations Act definitions: Section 4 preserves the Act’s definition of disclosing entity but adds a retail CCIV-specific clause: a retail CCIV is a disclosing entity in relation to a sub‑fund if any securities referable to the sub‑fund are ED securities within the meaning of subsection 1232F(2) of the Act (s 4(a)). The instrument therefore relies on definitions located elsewhere in the Act (s 9, s 1232F(2)) and specifically ties its treatment of retail CCIVs to those definitions.

Market operator and prescribed financial market interfaces: Section 6 requires notices to be given either to the operator of each prescribed financial market where the entity is listed or to ASIC if unlisted (s 6(2)(a)). The instrument therefore intersects with the regulatory framework governing financial markets and market operators. The operator(s) receiving notices will be operating under their own obligations in the Act and market rules; the instrument does not alter those operator obligations but creates an interaction whereby market operators are informed of an entity’s reliance on the relief.

Directors’ report and public record: The instrument requires the effect of the relief and reliance on it to be explained in the directors’ report for the relevant financial year (s 6(2)(b)). Because the directors’ report is a public document under the Act’s reporting regime (as set out in Chapter 2M), the instrument builds an interaction that ties exemption reliance to the public reporting system, enabling users of statutory reports to see when relief has been invoked.

Lines of enforcement remain with the Act: Because the instrument modifies application of Chapter 2M rather than creating substantive new offences or enforcement routes, any enforcement of reporting obligations or penalties remains governed by the Corporations Act. The instrument therefore interacts with enforcement provisions, penalties, and remedies set out elsewhere in the Act.

Notes and cross‑references preserved: The instrument itself contains explanatory notes that cross‑reference other Act provisions (s 6 notes referring to s 9 definition of "listed" and s 1222N regarding retail CCIVs). Those internal notes highlight points where the instrument’s relief is contingent on or informed by related provisions of the Corporations Act.

Compilation and amendment record: The instrument provides an endnote history showing its registration and commencement dates and a table of how provisions have been affected by later instruments (Endnote 1, Endnote 2). The original instrument, ASIC Corporations (Disclosing Entities) Instrument 2016/190, was registered on 25 August 2016 and commenced on 26 August 2016 (Endnote 1). Subsequent instruments amended it: Instrument 2016/1182 registered 15 December 2016 and commenced 20 December 2016; Instrument 2023/142 registered 4 January 2024 and commenced 5 January 2024 (Endnote 1).

Noted amendments to provisions: Endnote 2 sets out succinctly which provisions were added, amended, repealed or substituted. Relevant entries include:

• Section 4 was amended by 2023/142 (Endnote 2). That matches the insertion of the retail CCIV-specific definition in s 4(a).
• Subsection 5(1) was amended by 2023/142 and subsection 5(1A) was added by 2023/142 (Endnote 2). Subsection 5(1A) creates the separate relief rule for retail CCIVs that cease to be disclosing entities in relation to a sub‑fund (s 5(1A)).
• Subsection 5(2) was amended by 2023/142 (Endnote 2).
• Subsection 5(3) was repealed by 2016/1182 (Endnote 2) , the instrument’s current text shows no s 5(3).
• Subsection 6(1) was repealed and substituted by 2023/142 and subsection 6(2) was amended by 2023/142 (Endnote 2). The present s 6(1) sets the eight‑month test and the covered entity categories; the amendment history indicates the short-first-year relief framework was revised by the 2023 instrument.

Practical effect of amendment history: The endnotes show the instrument has been actively amended since its original 2016 inception, most recently by Instrument 2023/142 which came into force on 5 January 2024 (Endnote 1). The 2023 amendments introduced or refined the retail CCIV treatment and adjusted the two main relief provisions (ss 5 and 6). The table in Endnote 2 records the technical changes; the present operative text incorporates those amendments.

No transitional or saving provisions in compilation: The endnote table does not list specific transitional or saving rules attached to the most recent amendments in the compilation’s summary box (Endnote 1). The compilation notes that it includes any commenced amendment affecting the instrument up to 5 January 2024, but does not supply separate transitional provisions within the instrument’s text.

No cases or litigation recorded in the instrument: The instrument itself contains no judicial decisions, citations, or a litigation history. The endnotes record only the instrument history and amendment history, not any litigation or case law. There are no cases named in the text, and no references to judicial interpretation or challenges to the instrument’s operation.

Implication for practitioners: Because the instrument contains no recorded litigation history, users must rely on the plain text and on the Corporations Act for any interpretative questions. Any disputes over the scope or application of the relief (for example, whether an entity "stops being a disclosing entity" in time to qualify under s 5, or whether an entity's first financial year "lasts for 8 months or less" under s 6) would, in the absence of precedent recorded in the instrument, be matters for statutory interpretation and potentially for future litigation, but no authorities are provided by the instrument itself.

Monitoring for future decisions: Given the instrument’s interaction with Chapter 2M and the significance of directors’ resolutions and statutory reporting, regulatory or judicial interest could arise in future cases concerning the adequacy of directors’ resolutions, the sufficiency of notices to market operators or ASIC, or the meaning of "as if it had not been a disclosing entity" in s 5(2)(a). The instrument’s text does not preclude such litigation; it simply contains no litigation history as of this compilation date.

Timing is decisive and specific: The relief in s 5 is contingent on precise timing. For a company, the entity must stop being a disclosing entity before the earlier of three months after year end or, if the company is required to have an AGM, 21 days before the date of the next AGM after that year (s 5(1)(a)(i)-(ii)). For a scheme the relevant deadline is three months after year end (s 5(1)(b)). For retail CCIV sub‑funds the deadline is three months after year end (s 5(1A)). Entities that miss these windows cannot rely on the relief in s 5, even if they cease to be disclosing entities shortly thereafter.

Directors’ resolution timing and content: The directors’ resolution required by s 5(2)(b) must be passed before the earlier of the relevant deadlines. The resolution must state that there are no reasons to believe the entity may become a disclosing entity in the following financial year. That forward‑looking statement creates a governance risk: the instrument does not prescribe the evidentiary standard for "no reasons to believe", nor does it provide a safe‑harbour checklist; directors must exercise judgement and record their reasoning in the resolution. The instrument does not specify the form of the resolution beyond the content requirement.

Ambiguity in "comply with Chapter 2M … as if it had not been a disclosing entity": Section 5(2)(a) requires compliance "as if it had not been a disclosing entity at the end of the relevant financial year." That phrase could raise interpretive questions about which parts of Chapter 2M remain relevant and how to apply them in practice. The instrument does not provide worked examples or further clarification, so practitioners must map the practical implications against Chapter 2M.

Short-first-year notice deadlines and multiplicity of market operators: Under s 6(2)(a)(i)(B), listed entities must give notice to the operator of each prescribed financial market in relation to which they are listed. A listed entity trading on multiple markets may have to notify multiple operators. The instrument requires this notice "on or before the deadline for lodging the reports which would have been required to be prepared by section 302" (s 6(2) final paragraph). That deadline can be earlier or later depending on the entity’s reporting timetable and whether the entity is required to have an AGM. Practitioners must calculate the correct lodgement deadline under s 302 and ensure notices reach each market operator in time.

Retail CCIV nuances: The instrument’s treatment of retail CCIVs is specific. Section 4 defines when a retail CCIV is a disclosing entity in relation to a sub‑fund, referencing ED securities (s 4(a)) and subsection 1232F(2) of the Act. The notes in s 6 underline that a retail CCIV will be listed if its single sub‑fund is included in an official list even if the retail CCIV itself is not included, and that a retail CCIV with more than one sub‑fund or such a sub‑fund may not be listed (s 6 note 1-2). These nuances affect whether a retail CCIV must notify market operators or ASIC and whether the relief in s 5 and s 6 can be invoked.

Directors’ report disclosure requirement: For s 6 relief the directors’ report must explain the effect and state reliance on the section (s 6(2)(b)(i)-(ii)). Failure to include that explanation may undermine an entity’s ability to demonstrate it properly invoked the relief. The instrument mandates public disclosure in the directors’ report, so omitting that step is consequential.

No express penalty or safe‑harbour language: The instrument does not spell out penalties for incorrect reliance nor provide a safe‑harbour for inadvertent errors. Entities relying on the relief must therefore ensure compliance with the textual requirements; absent further guidance, any challenge to the validity of the relief invocation would refer back to the Act’s general enforcement mechanisms.

Notice content requirements are minimal but specific: The required notice must "explain the effect of this section and state that the entity intends to rely on it" (s 6(2)(a)(i)(B)-(ii)(B)). The instrument does not prescribe a required template or detail for the explanation, but the requirement to "explain the effect" suggests more than a bare formality and counsel should ensure the explanation is intelligible and adequate for the market operator or ASIC to assess the notice’s sufficiency.

Checklist approach focused on the instrument’s text:

1. Identify whether the entity is a "disclosing entity" for the relevant context. Use the Act’s definition in s 9, and for retail CCIVs apply s 4(a) which defines when a retail CCIV is a disclosing entity in relation to a sub‑fund if any securities referable to the sub‑fund are ED securities within the meaning of subsection 1232F(2) of the Act.

2. For cessation relief under s 5:

   • Determine the relevant financial year and whether the entity was a disclosing entity at its end (s 5(1)).
   • Confirm whether the entity stops being a disclosing entity within the applicable window: for companies the earlier of three months after year end or 21 days before the date of the next AGM (if required); for schemes three months after year end; for retail CCIV sub‑funds three months after year end (s 5(1), s 5(1A)).
   • Before the relevant deadline, have the directors formally resolve that there are no reasons to believe the entity may become a disclosing entity in the next financial year (s 5(2)(b)). Record the resolution in minutes and preserve supporting analysis.
   • Ensure the entity complies "with Chapter 2M … as if it had not been a disclosing entity at the end of the relevant financial year" where the instrument requires that (s 5(2)(a)). That may require legal review to identify which elements of Chapter 2M remain applicable.
   • Retain documentary evidence (board minutes, preparations, disclosures) to demonstrate the timing and substance of the directors’ resolution and related compliance steps.

3. For short-first-year relief under s 6:

   • Confirm the entity’s first financial year length is eight months or less (s 6(1)).
   • Decide whether the entity is listed or unlisted. For retail CCIVs consult the instrument’s notes on listing (s 6 note 1-2).
   • If listed, prepare and give a notice to the operator of each prescribed financial market in relation to which the entity is listed, explaining the effect of s 6 and stating that the entity intends to rely on it (s 6(2)(a)(i)(B)). If unlisted, prepare and give a notice to ASIC with the same contents (s 6(2)(a)(ii)(B)).
   • Give the notice on or before the lodgement deadline for the reports that would otherwise be required by s 302 (s 6(2) final paragraph). Confirm the lodgement deadline under s 302 calculations and calendar it.
   • Ensure the directors’ report for the relevant financial year explains the effect of s 6 and states that the entity relied on it (s 6(2)(b)(i)-(ii)). Draft and review the directors’ report language to ensure it meets the instrument’s requirement that it "explains the effect" and "states that the entity relied on it".
   • Preserve copies of notices sent to market operators or ASIC and any acknowledgements.

4. Recordkeeping and governance:

   • Maintain records of all relevant board resolutions, notices and directors’ report extracts. The instrument contemplates reliance on documentary proofs: directors’ resolutions (s 5(2)(b)) and directors’ report statements (s 6(2)(b)).
   • For listed entities with multiple market listings, ensure the notice is given to each operator of each prescribed financial market on which the entity is listed (s 6(2)(a)(i)).
   • For retail CCIVs, verify whether the retail CCIV’s structure means the single sub‑fund is treated as listed under the Act’s definition and whether multiple sub‑funds alter listing status (s 6 note 1-2).

5. Legal due diligence and internal sign‑offs:

   • Legal counsel should map the precise Chapter 2M obligations that would otherwise apply, to ensure the entity’s interpretation of "as if it had not been a disclosing entity" (s 5(2)(a)) is defensible.
   • Prepare scripted director briefing materials and minutes to document the basis for the directors’ forward‑looking resolution and to support the required directors’ report statements.
   • Coordinate with market operators’ compliance teams and ASIC (as applicable) to confirm receipt of notices and to address any follow‑up queries.

6. Practical time management:

   • Calculate all relevant deadlines early in the reporting cycle. For s 5 the three‑month and AGM-related timelines are absolute; for s 6 the notice must be given on or before the s 302 lodgement deadline. Missing those windows will prevent reliance on the relief.
   • Treat the directors’ report disclosure as a non‑negotiable final step: include the explanatory wording before finalising lodgement.

7. Audit and external reporting alignment:

   • Coordinate with auditors and external advisors so that financial statements and directors’ reports are consistent with any invocation of the instrument. The requirement that entities "comply with Chapter 2M … as if it had not been a disclosing entity" in s 5(2)(a) may have consequences for audit approaches and assurance statements.

Following these steps tracks the instrument’s text. The instrument does not provide templates, safe‑harbours or express penalty provisions; the principal compliance tasks are timing calculations, board decision‑making, preparing and lodging notices, and explaining reliance in the directors’ report (ss 5-6). Preservation of documentary evidence is essential in the absence of additional procedural guidance.